| Comparative analyses of inflammatory response and tissue integration of 14 hyaluronic acid-based fillers in mini pigs MS Choi, S Kwak, J Kim, MS Park, SM Ko, T Kim, DS Jeong, CH Rhee, ... Clinical, Cosmetic and Investigational Dermatology, 765-778, 2021 | 15 | 2021 |
| Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits J Kim, S Kwak, MS Park, CH Rhee, GH Yang, J Lee, WC Son, W Kang Plos one 16 (8), e0256869, 2021 | 12 | 2021 |
| Comparative pharmacodynamics study of 3 different botulinum toxin type A preparations in mice S Kwak, W Kang, CH Rhee, GH Yang, DJM Cruz Dermatologic Surgery 46 (12), e132-e138, 2020 | 11 | 2020 |
| Comparative analysis of hyaluronidase-mediated degradation among seven hyaluronic acid fillers in hairless mice SS Kwak, KH Yoon, JH Kwon, WH Kang, CH Rhee, GH Yang, DJM Cruz, ... Clinical, Cosmetic and Investigational Dermatology, 241-248, 2021 | 10 | 2021 |
| Model-based prediction to evaluate residence time of hyaluronic acid based dermal fillers H Ryu, S Kwak, C Rhee, G Yang, H Yun, W Kang Pharmaceutics 13 (2), 133, 2021 | 7 | 2021 |
| The role change of drug metabolism and pharmacokinetics research in the drug development W Kang, J Hwang, J Chae, K Kwon, H Yun Yakhak Hoeji 63 (3), 121-130, 2019 | 6 | 2019 |
| Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize … L Ngo, J Oh, A Kim, H Back, W Kang, J Chae, H Yun, H Lee CPT: Pharmacometrics & Systems Pharmacology 9 (10), 584-595, 2020 | 5 | 2020 |
| A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases H Ryu, W Kang, T Kim, JK Kim, KH Shin, J Chae, H Yun Frontiers in Pharmacology 13, 964049, 2022 | 4 | 2022 |
| Model-based anticancer effect of botulinum neurotoxin Type A1 on syngeneic melanoma mice WH Kang, HJ Ryu, S Kwak, HY Yun Frontiers in pharmacology 12, 793349, 2022 | 3 | 2022 |
| Combination of PD-1 checkpoint blockade and botulinum toxin type A1 improves antitumor responses in mouse tumor models of melanoma and colon carcinoma S Kwak, JY Lee, MJ Kim, HJ Lee, DK Lee, J Kang, W Kang, WC Son, ... Immunological Investigations 52 (6), 749-766, 2023 | 2 | 2023 |
| Comparative Pharmacodynamics of three different botulinum toxin type a preparations following repeated Intramuscular administration in Mice J Byun, S Kwak, JH Kwon, M Shin, DK Lee, CH Rhee, W Kang, JW Oh, ... Toxins 14 (6), 365, 2022 | 2 | 2022 |
| Population pharmacokinetic method to predict within-subject variability using single-period clinical data W Kang, J Lee, J Chae, KR Lee, I Baek, MS Kim, H Back, S Jung, ... Pharmaceuticals 14 (2), 114, 2021 | 2 | 2021 |
| Potential role of the cell‐penetrating peptide‐conjugated soluble N‐ethylmaleimide‐sensitive factor attachment protein receptor motif of vesicle‐associated membrane protein 2 … HJ Lee, D Kim, HJ Choi, S Kim, M Shin, S Kwak, DK Lee, W Kang Journal of Cosmetic Dermatology 23 (2), 666-675, 2024 | 1 | 2024 |
| Evaluation for Potential Drug–Drug Interaction of MT921 Using In Vitro Studies and Physiologically–Based Pharmacokinetic Models H Ryu, H Moon, J Lee, G Yang, S Yang, H Yun, J Chae, W Kang Pharmaceuticals 14 (7), 654, 2021 | 1 | 2021 |
| Compatibility Study between Physiologically Based Pharmacokinetic (PBPK) and Compartmental PK Model Using Lumping Method: Application to the Voriconazole Case H Ryu, W Kang, J Chae, H Yun Korean Journal of Clinical Pharmacy 31 (2), 125-135, 2021 | 1 | 2021 |
| Method for predicting the in vivo degradation time of hyaluronic acid hydrogel SK Won-ho Kang, Hyo-jeong Ryu KR Patent 10-2452582-0,000, 2022 | | 2022 |
| Agents for treating exosome-mediated disorders GHY Seongsung Kwak, Taekyeong Kim, Minju Kim, HyoJin Lee, Won-ho Kang KR Patent App. 10-2021-0,009,344, 2021 | | 2021 |
| Agents for treating cancers GHY Seongsung Kwak, Taekyeong Kim, HyoJin Lee, Won-ho Kang KR Patent App. 10-2021-0,074,544, 2021 | | 2021 |
| Preclinical formulation strategies for discovering new drug candidates W Kang, J Chae, H Yun Yakhak Hoeji 62 (3), 179-185, 2018 | | 2018 |
